Follow the 桂林三金 stock price and the full directors' dealings record of the company, a publicly traded company based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 桂林三金 has recorded 1 insider filings. Market capitalisation: €7.8bn. The latest transaction was disclosed on 26 April 2024 (Purchase). Among the most active insiders: 邹洵. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
桂林三金是一家健康和制药行业的公司,以其中药产品而闻名。该公司在深圳证券交易所上市。